Reviewer_1_v.1 – Supplemental material for Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial
- Resource Type
- Source
- Subject
110203 Respiratory Diseases FOS: Clinical medicine 111702 Aged Health Care FOS: Health sciences 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified - Language